[
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_321",
        "immunotherapy_type": null,
        "drug_name": "Tagrisso",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_322",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_323",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Vandetanib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_324",
        "immunotherapy_type": null,
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_325",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Lynparza",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_326",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Trastuzumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_327",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Tarceva",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_328",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Trastuzumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_329",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_330",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Niraparib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_331",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Tagrisso",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_332",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_333",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_334",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Herceptin",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_335",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_336",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ado-trastuzumab emtansine",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_337",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Enhertu",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_338",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_339",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Alecensa",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_340",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Rituxan",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_341",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Ceritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_342",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Vemurafenib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_343",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Axicabtagene ciloleucel",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_344",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_345",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_346",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Dabrafenib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_347",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Rubraca",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_348",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_349",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_350",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_351",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_352",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_353",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Brigatinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_354",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Venetoclax",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_355",
        "immunotherapy_type": null,
        "drug_name": "Abemaciclib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_356",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_357",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_358",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_359",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Yescarta",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_360",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Lynparza",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_361",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Crizotinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_362",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_363",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Tarceva",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_364",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Herceptin",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_365",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Niraparib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_366",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_367",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Tarceva",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_368",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_369",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ibrance",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_370",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Verzenio",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_371",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Erlotinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_372",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Caprelsa",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_373",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Verzenio",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_374",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_375",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_376",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Niraparib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_377",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Opdivo",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_378",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Rituxan",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_379",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_380",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Caprelsa",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_381",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Xalkori",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_382",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Vandetanib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_383",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_384",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Blinatumomab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_385",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Adcetris",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_386",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Nexavar",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_387",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_388",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_389",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Darzalex",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_390",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_391",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_392",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_393",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_394",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_395",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Niraparib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_396",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_397",
        "immunotherapy_type": null,
        "drug_name": "Brentuximab vedotin",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_398",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Perjeta",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_399",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Zejula",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_400",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_321",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_322",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_323",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Daratumumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_324",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_325",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ibrance",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_326",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Tarceva",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_327",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_328",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilotrif",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_329",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Cabozantinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_330",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Kisqali",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_331",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Trametinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_332",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Caprelsa",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_333",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_334",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Yescarta",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_335",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_336",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_337",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Opdivo",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_338",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_339",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_340",
        "immunotherapy_type": null,
        "drug_name": "Gefitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_341",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_342",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gefitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_343",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_344",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Verzenio",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_345",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Nexavar",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_346",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_347",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pertuzumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 124,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_348",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Cabozantinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_349",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Cabozantinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_350",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gefitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_351",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_352",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Sorafenib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_353",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 58,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_354",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_355",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_356",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Venclexta",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_357",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Lenvima",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_358",
        "immunotherapy_type": null,
        "drug_name": "Cobimetinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_359",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_360",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_361",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Alecensa",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_362",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_363",
        "immunotherapy_type": null,
        "drug_name": "Verzenio",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_364",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_365",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Trastuzumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_366",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_367",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_368",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Mektovi",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_369",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_370",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_371",
        "immunotherapy_type": null,
        "drug_name": "Zejula",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_372",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_373",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_374",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_375",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_376",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_377",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Zykadia",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_378",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gazyva",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_379",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Daratumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_380",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Trametinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_381",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_382",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_383",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Tagrisso",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_384",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Cobimetinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_385",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Venetoclax",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_386",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_387",
        "immunotherapy_type": null,
        "drug_name": "Opdivo",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_388",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Nexavar",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_389",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_390",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Alunbrig",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_391",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_392",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Rucaparib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_393",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_394",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gazyva",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_395",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Blincyto",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_396",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Fam-trastuzumab deruxtecan-nxki",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_397",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_398",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_399",
        "immunotherapy_type": null,
        "drug_name": "Inotuzumab ozogamicin",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_400",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_321",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Afatinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_322",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Osimertinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_323",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Alunbrig",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_324",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Xalkori",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_325",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_326",
        "immunotherapy_type": null,
        "drug_name": "Olaparib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_327",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Binimetinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_328",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_329",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Sorafenib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_330",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Niraparib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_331",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Tafinlar",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_332",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Zykadia",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_333",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 80,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_334",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gazyva",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_335",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_336",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_337",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Trastuzumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_338",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_339",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_340",
        "immunotherapy_type": null,
        "drug_name": "Alecensa",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_341",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_342",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Rucaparib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_343",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_344",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_345",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Opdivo",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_346",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_347",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Lynparza",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_348",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gazyva",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_349",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Darzalex",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_350",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Zejula",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_351",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Trametinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_352",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilotrif",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_353",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Braftovi",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_354",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Besponsa",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_355",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_356",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Sorafenib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_357",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 197
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_358",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Tisagenlecleucel",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_359",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Afatinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_360",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Xalkori",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_361",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_362",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_363",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Besponsa",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_364",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_365",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Palbociclib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_366",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_367",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_368",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_369",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Tarceva",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_370",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_371",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Iressa",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_372",
        "immunotherapy_type": null,
        "drug_name": "Gilotrif",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_373",
        "immunotherapy_type": null,
        "drug_name": "Yervoy",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_374",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Brentuximab vedotin",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_375",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_376",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_377",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_378",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_379",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ibrance",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_380",
        "immunotherapy_type": null,
        "drug_name": "Vemurafenib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_381",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 149,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_382",
        "immunotherapy_type": null,
        "drug_name": "Tarceva",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_383",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Vemurafenib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_384",
        "immunotherapy_type": null,
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_385",
        "immunotherapy_type": null,
        "drug_name": "Yervoy",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_386",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Binimetinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_387",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Inotuzumab ozogamicin",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_388",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Cabozantinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_389",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Abemaciclib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_390",
        "immunotherapy_type": null,
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_391",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_392",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Sorafenib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_393",
        "immunotherapy_type": null,
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_394",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Venclexta",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_395",
        "immunotherapy_type": null,
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_396",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Zykadia",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_397",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Venclexta",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_398",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_399",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_400",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_321",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Blincyto",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_322",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Zelboraf",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_323",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Zejula",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_324",
        "immunotherapy_type": null,
        "drug_name": "Nexavar",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_325",
        "immunotherapy_type": null,
        "drug_name": "Rituxan",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_326",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Herceptin",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_327",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Erlotinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_328",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_329",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Kadcyla",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_330",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Dabrafenib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_331",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Mektovi",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_332",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Kadcyla",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_333",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_334",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_335",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_336",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_337",
        "immunotherapy_type": null,
        "drug_name": "Yervoy",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_338",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Adcetris",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_339",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_340",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Darzalex",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_341",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Iressa",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_342",
        "immunotherapy_type": null,
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_343",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_344",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_345",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_346",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Caprelsa",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_347",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_348",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Trametinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_349",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Xalkori",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_350",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Abemaciclib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_351",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Erlotinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_352",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Tisagenlecleucel",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_353",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_354",
        "immunotherapy_type": null,
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_355",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Rituxan",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_356",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_357",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_358",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Rituxan",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_359",
        "immunotherapy_type": null,
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_360",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Palbociclib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_361",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_362",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_363",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_364",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_365",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Encorafenib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_366",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Opdivo",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_367",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Tarceva",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_368",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_369",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Mektovi",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_370",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_371",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_372",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_373",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_374",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gefitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 127,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_375",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_376",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ribociclib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_377",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 86
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_378",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Enhertu",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_379",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_380",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Afatinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_381",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_382",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Enhertu",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_383",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilotrif",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_384",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_385",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Obinutuzumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_386",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_387",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Braftovi",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_388",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_389",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Binimetinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_390",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Blinatumomab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_391",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Cobimetinib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_392",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_393",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Fam-trastuzumab deruxtecan-nxki",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_394",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Zelboraf",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_395",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Kisqali",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_396",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gazyva",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_397",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_398",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Zelboraf",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_399",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Tagrisso",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_400",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_321",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Cometriq",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_322",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Tisagenlecleucel",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_323",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_324",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Zelboraf",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 59
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_325",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_326",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Mekinist",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_327",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Venclexta",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_328",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Lynparza",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_329",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ibrance",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_330",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_331",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Yervoy",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_332",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Trametinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_333",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_334",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_335",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Inotuzumab ozogamicin",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_336",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Sorafenib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_337",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_338",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Rucaparib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_339",
        "immunotherapy_type": null,
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_340",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_341",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Yescarta",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_342",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_343",
        "immunotherapy_type": null,
        "drug_name": "Zykadia",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_344",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_345",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Nexavar",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_346",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Alecensa",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_347",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Yescarta",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_348",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Lenvatinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_349",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_350",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Cobimetinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_351",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_352",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_353",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Inotuzumab ozogamicin",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_354",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Rubraca",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_355",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Vandetanib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_356",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Encorafenib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_357",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gefitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_358",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Ibrance",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_359",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilotrif",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 56,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_360",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_361",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Tafinlar",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_362",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Tisagenlecleucel",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_363",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_364",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Dabrafenib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_365",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Fam-trastuzumab deruxtecan-nxki",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_366",
        "immunotherapy_type": null,
        "drug_name": "Vemurafenib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_367",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Herceptin",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_368",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Abemaciclib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_369",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Crizotinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_370",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Zykadia",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_371",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Axicabtagene ciloleucel",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_372",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Rituxan",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_373",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Daratumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_374",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Adcetris",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_375",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_376",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Crizotinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_377",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Alecensa",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_378",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Iressa",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_379",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_380",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_381",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_382",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Cobimetinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_383",
        "immunotherapy_type": null,
        "drug_name": "Osimertinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_384",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_385",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Caprelsa",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_386",
        "immunotherapy_type": null,
        "drug_name": "Sorafenib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 59,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_387",
        "immunotherapy_type": null,
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_388",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Nexavar",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_389",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Lenvatinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_390",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 111
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_391",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Binimetinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_392",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Rituximab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_393",
        "immunotherapy_type": null,
        "drug_name": "Mekinist",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_394",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Encorafenib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_395",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Alunbrig",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_396",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Caprelsa",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_397",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_398",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Lynparza",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_399",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Perjeta",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_400",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 119,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_321",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Iressa",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_322",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Cometriq",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_323",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Braftovi",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_324",
        "immunotherapy_type": null,
        "drug_name": "Rituxan",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 53
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_325",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Rubraca",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_326",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Darzalex",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_327",
        "immunotherapy_type": null,
        "drug_name": "Tisagenlecleucel",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_328",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Tarceva",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_329",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Yescarta",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_330",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Blincyto",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_331",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Niraparib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_332",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Olaparib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_333",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_334",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Enhertu",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_335",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Ribociclib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_336",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Zykadia",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_337",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Verzenio",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_338",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Afatinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_339",
        "immunotherapy_type": null,
        "drug_name": "Palbociclib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_340",
        "immunotherapy_type": null,
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_341",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Axicabtagene ciloleucel",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_342",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Cabozantinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 167
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_343",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Perjeta",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_344",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_345",
        "immunotherapy_type": null,
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_346",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Keytruda",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_347",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_348",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Alectinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_349",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_350",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_351",
        "immunotherapy_type": null,
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_352",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_353",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 167,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_354",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Alectinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_355",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Alectinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_356",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_357",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_358",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_359",
        "immunotherapy_type": null,
        "drug_name": "Cobimetinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_360",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_361",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_362",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_363",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Tisagenlecleucel",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_364",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Afatinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_365",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Zejula",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_366",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Rituxan",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_367",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_368",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Lenvatinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_369",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_370",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Zykadia",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_371",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 178,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_372",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Lenvatinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_373",
        "immunotherapy_type": null,
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_374",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_375",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Cometriq",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_376",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Xalkori",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_377",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Cabozantinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_378",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Zykadia",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_379",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Rubraca",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_380",
        "immunotherapy_type": null,
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_381",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_382",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Dabrafenib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_383",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 179,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_384",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_385",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_386",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Rucaparib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_387",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ceritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_388",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gefitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_389",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Blincyto",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_390",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_391",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gazyva",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_392",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Kisqali",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 106,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_393",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Xalkori",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_394",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_395",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_396",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_397",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_398",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_399",
        "immunotherapy_type": null,
        "drug_name": "Imfinzi",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_400",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_321",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Kymriah",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_322",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_323",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_324",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Nexavar",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_325",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_326",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_327",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Cotellic",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_328",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Olaparib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_329",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Tarceva",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_330",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_331",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Binimetinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_332",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_333",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Yescarta",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_334",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_335",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_336",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Alecensa",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_337",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 94,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_338",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 161,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_339",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Blinatumomab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_340",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_341",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Lenvatinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_342",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_343",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Cobimetinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_344",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ceritinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_345",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Perjeta",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_346",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Alunbrig",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_347",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Axicabtagene ciloleucel",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_348",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_349",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Iressa",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_350",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_351",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_352",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Olaparib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_353",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_354",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Axicabtagene ciloleucel",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_355",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_356",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pertuzumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_357",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_358",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Kymriah",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 185,
        "actual_cumulative_drug_dose": 67
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_359",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Vemurafenib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_360",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_361",
        "immunotherapy_type": null,
        "drug_name": "Darzalex",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_362",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_363",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_364",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Niraparib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_365",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_366",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Trametinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_367",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Niraparib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_368",
        "immunotherapy_type": null,
        "drug_name": "Opdivo",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_369",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Blinatumomab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_370",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Adcetris",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 135
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_371",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_372",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Perjeta",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_373",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Encorafenib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_374",
        "immunotherapy_type": null,
        "drug_name": "Cometriq",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_375",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Ado-trastuzumab emtansine",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_376",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_377",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Brigatinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_378",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Trametinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_379",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Rituximab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_380",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Mektovi",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_381",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_382",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_383",
        "immunotherapy_type": null,
        "drug_name": "Encorafenib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_384",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_385",
        "immunotherapy_type": null,
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_386",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_387",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_388",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Lenvima",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 186
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_389",
        "immunotherapy_type": null,
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_390",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_391",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_392",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Zejula",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_393",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Brentuximab vedotin",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_394",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_395",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_396",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_397",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_398",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_399",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Caprelsa",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_400",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Crizotinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_321",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Lenvatinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_322",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Alectinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_323",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_324",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Cabozantinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_325",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Cobimetinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_326",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Brentuximab vedotin",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_327",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_328",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_329",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Cabozantinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_330",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_331",
        "immunotherapy_type": null,
        "drug_name": "Lynparza",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 119
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_332",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_333",
        "immunotherapy_type": null,
        "drug_name": "Daratumumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_334",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Alecensa",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_335",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_336",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_337",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ribociclib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_338",
        "immunotherapy_type": null,
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_339",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Cabozantinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_340",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Axicabtagene ciloleucel",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_341",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_342",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Sorafenib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_343",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Keytruda",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 61,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_344",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Mektovi",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 195,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_345",
        "immunotherapy_type": null,
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_346",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Tisagenlecleucel",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_347",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Abemaciclib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_348",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Rituxan",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_349",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 107,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_350",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Abemaciclib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_351",
        "immunotherapy_type": null,
        "drug_name": "Mekinist",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_352",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Kadcyla",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_353",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Kisqali",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_354",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_355",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_356",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_357",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_358",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Besponsa",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_359",
        "immunotherapy_type": null,
        "drug_name": "Erlotinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_360",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_361",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 87
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_362",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_363",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_364",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_365",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Verzenio",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_366",
        "immunotherapy_type": null,
        "drug_name": "Daratumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_367",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Ribociclib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_368",
        "immunotherapy_type": null,
        "drug_name": "Olaparib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_369",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 116,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_370",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_371",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_372",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_373",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_374",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Trastuzumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_375",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Vandetanib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_376",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_377",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_378",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Tisagenlecleucel",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_379",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_380",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_381",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_382",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_383",
        "immunotherapy_type": null,
        "drug_name": "Brentuximab vedotin",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_384",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Obinutuzumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_385",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 70
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_386",
        "immunotherapy_type": null,
        "drug_name": "Nivolumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_387",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 60
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_388",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Venclexta",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_389",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_390",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Niraparib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_391",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Keytruda",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 140,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_392",
        "immunotherapy_type": null,
        "drug_name": "Opdivo",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_393",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Cobimetinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_394",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Perjeta",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_395",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Encorafenib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_396",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Verzenio",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_397",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_398",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_399",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Lynparza",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_400",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Adcetris",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_321",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Crizotinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_322",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_323",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_324",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 181,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_325",
        "immunotherapy_type": null,
        "drug_name": "Ribociclib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_326",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Venetoclax",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_327",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_328",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Tafinlar",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_329",
        "immunotherapy_type": null,
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_330",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Kadcyla",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_331",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Besponsa",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_332",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Palbociclib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_333",
        "immunotherapy_type": null,
        "drug_name": "Nexavar",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 189,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_334",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Lynparza",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_335",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_336",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_337",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Ceritinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_338",
        "immunotherapy_type": null,
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_339",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_340",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 118,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_341",
        "immunotherapy_type": null,
        "drug_name": "Axicabtagene ciloleucel",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_342",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_343",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Trastuzumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_344",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_345",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_346",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Cobimetinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_347",
        "immunotherapy_type": null,
        "drug_name": "Ibrance",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_348",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_349",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_350",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_351",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 76,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_352",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Brigatinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_353",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Ibrance",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_354",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Lenvima",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 120
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_355",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ibrance",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 117
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_356",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_357",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Crizotinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_358",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Kisqali",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 188,
        "actual_cumulative_drug_dose": 170
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_359",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Olaparib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_360",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gazyva",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_361",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 165,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_362",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Herceptin",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_363",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Lenvatinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_364",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 62
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_365",
        "immunotherapy_type": null,
        "drug_name": "Kisqali",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_366",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Kisqali",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_367",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_368",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Alectinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 189
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_369",
        "immunotherapy_type": null,
        "drug_name": "Lynparza",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 103,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_370",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Niraparib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_371",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 72
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_372",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Blinatumomab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_373",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Osimertinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": 148
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_374",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_375",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_376",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Iressa",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 151
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_377",
        "immunotherapy_type": null,
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 51,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_378",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_379",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 93
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_380",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ado-trastuzumab emtansine",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_381",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Kymriah",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_382",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Trametinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 121,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_383",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Zejula",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_384",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Olaparib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 123,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_385",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Erlotinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 112,
        "actual_cumulative_drug_dose": 68
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_386",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Alecensa",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 134
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_387",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Erlotinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_388",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pertuzumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 85,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_389",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Verzenio",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_390",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Alecensa",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_391",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 172
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_392",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Kadcyla",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_393",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Trametinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_394",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Lenvatinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_395",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_396",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_397",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_398",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Trastuzumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_399",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Cobimetinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_400",
        "immunotherapy_type": null,
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_321",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_322",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Tagrisso",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 174,
        "actual_cumulative_drug_dose": 136
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_323",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Mektovi",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 74,
        "actual_cumulative_drug_dose": 58
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_324",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Blinatumomab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_325",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Sorafenib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 181
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_326",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Nexavar",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_327",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_328",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_329",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilotrif",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 190
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_330",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Yescarta",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 96
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_331",
        "immunotherapy_type": null,
        "drug_name": "Besponsa",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 144
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_332",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_333",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Verzenio",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 88,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_334",
        "immunotherapy_type": null,
        "drug_name": "Brigatinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 86,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_335",
        "immunotherapy_type": null,
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_336",
        "immunotherapy_type": null,
        "drug_name": "Alunbrig",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 164
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_337",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 182,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_338",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Zejula",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_339",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Rubraca",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_340",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Cabozantinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_341",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_342",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_343",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Yervoy",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_344",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Venclexta",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_345",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_346",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Encorafenib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_347",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 114,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_348",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Zykadia",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 187
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_349",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_350",
        "immunotherapy_type": null,
        "drug_name": "Opdivo",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 186,
        "actual_cumulative_drug_dose": 99
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_351",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Fam-trastuzumab deruxtecan-nxki",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_352",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 135,
        "actual_cumulative_drug_dose": 200
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_353",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Lenvima",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 122
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_354",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Xalkori",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_355",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Vandetanib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 90,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_356",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Herceptin",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 61
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_357",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Kymriah",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_358",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Vandetanib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 55
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_359",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_360",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 65
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_361",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 89
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_362",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Trastuzumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 191
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_363",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_364",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_365",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_366",
        "immunotherapy_type": null,
        "drug_name": "Zejula",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_367",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Ribociclib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 131
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_368",
        "immunotherapy_type": null,
        "drug_name": "Rucaparib",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 87,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_369",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_370",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 169,
        "actual_cumulative_drug_dose": 51
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_371",
        "immunotherapy_type": null,
        "drug_name": "Rituximab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_372",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_373",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Encorafenib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_374",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Vandetanib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": 126
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_375",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 50
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_376",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Erlotinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_377",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Blinatumomab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 127
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_378",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 141
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_379",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 154,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_380",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 147,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_381",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Inotuzumab ozogamicin",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_382",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 132,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_383",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Herceptin",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 95
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_384",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Trametinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_385",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Palbociclib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 125,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_386",
        "immunotherapy_type": null,
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_387",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 193,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_388",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Cobimetinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_389",
        "immunotherapy_type": null,
        "drug_name": "Vemurafenib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 108,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_390",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_391",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Osimertinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 198,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_392",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_393",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Dabrafenib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 72,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_394",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_395",
        "immunotherapy_type": null,
        "drug_name": "Lenvatinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_396",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 117,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_397",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Niraparib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_398",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 54
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_399",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 136,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_400",
        "immunotherapy_type": null,
        "drug_name": "Zykadia",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_401",
        "immunotherapy_type": null,
        "drug_name": "Venetoclax",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_402",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Nexavar",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 138
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_403",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_404",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Afatinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 111,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_405",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 73
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_406",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_407",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Rubraca",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_408",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 50,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_409",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 52,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_410",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Cometriq",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 144,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_411",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_412",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 162
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_413",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 91,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_414",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Perjeta",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 168,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_415",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gefitinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_416",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Binimetinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_417",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Lenvima",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_418",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_419",
        "immunotherapy_type": null,
        "drug_name": "Tarceva",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_420",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 180
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_421",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_422",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_423",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 176,
        "actual_cumulative_drug_dose": 156
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_424",
        "immunotherapy_type": null,
        "drug_name": "Imfinzi",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 143
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_425",
        "immunotherapy_type": null,
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 157
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_426",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_427",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Trastuzumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_428",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_429",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Alunbrig",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_430",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Blincyto",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 97
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_431",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Rituximab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 112
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_432",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 152,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_433",
        "immunotherapy_type": null,
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 109,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_434",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 70,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_435",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_436",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Venetoclax",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 128
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_437",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Osimertinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_438",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_439",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Herceptin",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_440",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Lenvatinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 78
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_401",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_402",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_403",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 101
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_404",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilotrif",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_405",
        "immunotherapy_type": null,
        "drug_name": "Afatinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_406",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_407",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Dabrafenib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 173
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_408",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Cobimetinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 146
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_409",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Afatinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 104
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_410",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 129
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_411",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Cobimetinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_412",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 197,
        "actual_cumulative_drug_dose": 85
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_413",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Venetoclax",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_414",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Brigatinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 143,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_415",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_416",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Yescarta",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_417",
        "immunotherapy_type": null,
        "drug_name": "Perjeta",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 53,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_418",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_419",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 133
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_420",
        "immunotherapy_type": null,
        "drug_name": "Keytruda",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_421",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Blinatumomab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 175,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_422",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Afatinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 137
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_423",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Osimertinib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_424",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ribociclib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_425",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 96,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_426",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 110
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_427",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Keytruda",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_428",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Obinutuzumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_429",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 153,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_430",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 140
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_431",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Palbociclib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 133,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_432",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": null,
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 106
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_433",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Rituximab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_434",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Gazyva",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 67,
        "actual_cumulative_drug_dose": 176
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_435",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Adcetris",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 184
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_436",
        "immunotherapy_type": null,
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 102,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_437",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 75
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_438",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Kisqali",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 99,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_439",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Brigatinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 138,
        "actual_cumulative_drug_dose": 145
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_440",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Binimetinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 157,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_401",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 57,
        "actual_cumulative_drug_dose": 171
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_402",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 128,
        "actual_cumulative_drug_dose": 77
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_403",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Adcetris",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 139
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_404",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Venclexta",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_405",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Alectinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 174
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_406",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Abemaciclib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_407",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gazyva",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_408",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Dabrafenib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 166
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_409",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 187,
        "actual_cumulative_drug_dose": 74
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_410",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Rucaparib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 152
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_411",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_412",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Keytruda",
        "drug_reference_identifier": null,
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 166,
        "actual_cumulative_drug_dose": 82
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_413",
        "immunotherapy_type": null,
        "drug_name": "Sorafenib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 159,
        "actual_cumulative_drug_dose": 57
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_414",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Palbociclib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_415",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 180,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_416",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 92,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_417",
        "immunotherapy_type": null,
        "drug_name": "Lenvatinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 123
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_418",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Axicabtagene ciloleucel",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 100,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_419",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 139,
        "actual_cumulative_drug_dose": 165
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_420",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 150,
        "actual_cumulative_drug_dose": 149
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_421",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Alectinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 64,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_422",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 98
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_423",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Blincyto",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_424",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_425",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Verzenio",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 178
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_426",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 175
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_427",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 79
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_428",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 129,
        "actual_cumulative_drug_dose": 185
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_429",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 107
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_430",
        "immunotherapy_type": null,
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_431",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Alecensa",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 126,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_432",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ceritinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_433",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Darzalex",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 194
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_434",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 172,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_435",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Cabozantinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 158,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_436",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_437",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 155
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_438",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 198
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_439",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 162,
        "actual_cumulative_drug_dose": 108
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_440",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "239766",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 146,
        "actual_cumulative_drug_dose": 116
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_401",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Trametinib",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 115,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_402",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 192,
        "actual_cumulative_drug_dose": 153
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_403",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Darzalex",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 73,
        "actual_cumulative_drug_dose": 91
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_404",
        "immunotherapy_type": null,
        "drug_name": null,
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 142,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_405",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Besponsa",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_406",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 183
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_407",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Belantamab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 199,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_408",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 56
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_409",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 177,
        "actual_cumulative_drug_dose": 169
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_410",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Durvalumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_411",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 156,
        "actual_cumulative_drug_dose": 52
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_412",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Braftovi",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 141,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_413",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 132
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_414",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 160
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_415",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 55,
        "actual_cumulative_drug_dose": 168
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_416",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_417",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Xalkori",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 164,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_418",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 90
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_419",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Axicabtagene ciloleucel",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 184,
        "actual_cumulative_drug_dose": 159
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_420",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 154
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_421",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 62,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_422",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 97,
        "actual_cumulative_drug_dose": 182
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_423",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Alunbrig",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 155,
        "actual_cumulative_drug_dose": 80
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_424",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_425",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 69,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_426",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 77,
        "actual_cumulative_drug_dose": 94
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_427",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Binimetinib",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 60,
        "actual_cumulative_drug_dose": 192
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_428",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Tecentriq",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 68,
        "actual_cumulative_drug_dose": 179
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_429",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gazyva",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 81,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_430",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 103
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_431",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Axicabtagene ciloleucel",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 120,
        "actual_cumulative_drug_dose": 88
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_432",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Tarceva",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 190,
        "actual_cumulative_drug_dose": 199
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_433",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Cabozantinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_434",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Pembrolizumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_435",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Zykadia",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 125
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_436",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 110,
        "actual_cumulative_drug_dose": 100
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_437",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Ado-trastuzumab emtansine",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 83,
        "actual_cumulative_drug_dose": 66
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_438",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 113,
        "actual_cumulative_drug_dose": 177
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_439",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Yervoy",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 122,
        "actual_cumulative_drug_dose": 130
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_440",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Axicabtagene ciloleucel",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 104,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_1",
        "submitter_treatment_id": "TREATMENT_441",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Lynparza",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 130,
        "actual_cumulative_drug_dose": 63
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_2",
        "submitter_treatment_id": "TREATMENT_442",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Copanlisib",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_3",
        "submitter_treatment_id": "TREATMENT_443",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gazyva",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 173,
        "actual_cumulative_drug_dose": 193
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_4",
        "submitter_treatment_id": "TREATMENT_444",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 79,
        "actual_cumulative_drug_dose": 109
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_5",
        "submitter_treatment_id": "TREATMENT_445",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Iressa",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 82,
        "actual_cumulative_drug_dose": 81
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_6",
        "submitter_treatment_id": "TREATMENT_446",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Zykadia",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 200,
        "actual_cumulative_drug_dose": 161
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_7",
        "submitter_treatment_id": "TREATMENT_447",
        "immunotherapy_type": null,
        "drug_name": "Imfinzi",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 95,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_8",
        "submitter_treatment_id": "TREATMENT_448",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 196,
        "actual_cumulative_drug_dose": 163
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_9",
        "submitter_treatment_id": "TREATMENT_449",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Selumitinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 84
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_10",
        "submitter_treatment_id": "TREATMENT_450",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ado-trastuzumab emtansine",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": 150
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_11",
        "submitter_treatment_id": "TREATMENT_451",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Opdivo",
        "drug_reference_identifier": "239766",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 71,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_12",
        "submitter_treatment_id": "TREATMENT_452",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Cabozantinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 64
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_13",
        "submitter_treatment_id": "TREATMENT_453",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Adcetris",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 113
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_14",
        "submitter_treatment_id": "TREATMENT_454",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Daratumumab",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 170,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_15",
        "submitter_treatment_id": "TREATMENT_455",
        "immunotherapy_type": null,
        "drug_name": "Pexidartinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 105,
        "actual_cumulative_drug_dose": 196
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_16",
        "submitter_treatment_id": "TREATMENT_456",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Herceptin",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 171,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_17",
        "submitter_treatment_id": "TREATMENT_457",
        "immunotherapy_type": null,
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 148,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_18",
        "submitter_treatment_id": "TREATMENT_458",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Verzenio",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 63,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_19",
        "submitter_treatment_id": "TREATMENT_459",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Rituxan",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 151,
        "actual_cumulative_drug_dose": 142
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_20",
        "submitter_treatment_id": "TREATMENT_460",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 93,
        "actual_cumulative_drug_dose": 71
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_21",
        "submitter_treatment_id": "TREATMENT_461",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_22",
        "submitter_treatment_id": "TREATMENT_462",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Keytruda",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 188
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_23",
        "submitter_treatment_id": "TREATMENT_463",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Binimetinib",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "g/m2",
        "prescribed_cumulative_drug_dose": 89,
        "actual_cumulative_drug_dose": 115
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_24",
        "submitter_treatment_id": "TREATMENT_464",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Trametinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 66,
        "actual_cumulative_drug_dose": 92
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_25",
        "submitter_treatment_id": "TREATMENT_465",
        "immunotherapy_type": "Immune checkpoint inhibitors",
        "drug_name": "Atezolizumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 194,
        "actual_cumulative_drug_dose": 124
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_26",
        "submitter_treatment_id": "TREATMENT_466",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Necitumumab",
        "drug_reference_identifier": null,
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 183,
        "actual_cumulative_drug_dose": 195
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_27",
        "submitter_treatment_id": "TREATMENT_467",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Kymriah",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 163,
        "actual_cumulative_drug_dose": 118
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_28",
        "submitter_treatment_id": "TREATMENT_468",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Gilteritinib",
        "drug_reference_identifier": "8756456",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/kg",
        "prescribed_cumulative_drug_dose": 75,
        "actual_cumulative_drug_dose": 105
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_29",
        "submitter_treatment_id": "TREATMENT_469",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Lenvima",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": "IU/kg",
        "prescribed_cumulative_drug_dose": 191,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_30",
        "submitter_treatment_id": "TREATMENT_470",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": null,
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "IU/m2",
        "prescribed_cumulative_drug_dose": 145,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_31",
        "submitter_treatment_id": "TREATMENT_471",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": null,
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 137,
        "actual_cumulative_drug_dose": 69
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_32",
        "submitter_treatment_id": "TREATMENT_472",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Daratumumab",
        "drug_reference_identifier": "278936",
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 160,
        "actual_cumulative_drug_dose": 102
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_33",
        "submitter_treatment_id": "TREATMENT_473",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Ipilimumab",
        "drug_reference_identifier": "8836851",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 131,
        "actual_cumulative_drug_dose": 76
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_34",
        "submitter_treatment_id": "TREATMENT_474",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 84,
        "actual_cumulative_drug_dose": 83
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_35",
        "submitter_treatment_id": "TREATMENT_475",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Gilotrif",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "mg/m2",
        "prescribed_cumulative_drug_dose": 65,
        "actual_cumulative_drug_dose": 121
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_36",
        "submitter_treatment_id": "TREATMENT_476",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Nivolumab",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": null,
        "actual_cumulative_drug_dose": 147
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_37",
        "submitter_treatment_id": "TREATMENT_477",
        "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors",
        "drug_name": "Kadcyla",
        "drug_reference_identifier": "4459876",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "cells/kg",
        "prescribed_cumulative_drug_dose": 101,
        "actual_cumulative_drug_dose": 114
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_38",
        "submitter_treatment_id": "TREATMENT_478",
        "immunotherapy_type": "Cell-based",
        "drug_name": null,
        "drug_reference_identifier": "278936",
        "drug_reference_database": "RxNorm",
        "immunotherapy_drug_dose_units": null,
        "prescribed_cumulative_drug_dose": 134,
        "actual_cumulative_drug_dose": 158
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_39",
        "submitter_treatment_id": "TREATMENT_479",
        "immunotherapy_type": "Other immunomodulatory substances",
        "drug_name": "Brigatinib",
        "drug_reference_identifier": "987654",
        "drug_reference_database": "NCI Thesaurus",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 98,
        "actual_cumulative_drug_dose": null
    },
    {
        "program_id": "SYNTHETIC-1",
        "submitter_donor_id": "DONOR_40",
        "submitter_treatment_id": "TREATMENT_480",
        "immunotherapy_type": "Cell-based",
        "drug_name": "Kisqali",
        "drug_reference_identifier": null,
        "drug_reference_database": "PubChem",
        "immunotherapy_drug_dose_units": "ug/m2",
        "prescribed_cumulative_drug_dose": 54,
        "actual_cumulative_drug_dose": 132
    }
]